ClinicalTrials.gov
public full text
Public Domain
Monoclonal Antibodies in Clostridium Difficile Infection
Immunoglobulin A (IgA), the major mucosal antibody, plays a key role in maintaining diversity of the intestinal microbiota and eliminating intestinal pathogens. Dysbiosis is an important risk factor for Clostridium difficile infection, which is the leading cause of nosocomial diarrhea in industrialized countries. This study aims to develop IgA monoclonal antibodies targeting C. difficile surface proteins.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Elucidating the pleiotropic effects of clpC deletion in Clostridioides difficile: proteomic and phenotypic insights#1134116
- BALANCING PROTECTION AND PATHOLOGY: REGULATION OF INTESTINAL INNATE IMMUNITY DURING CLOSTRIDIOIDES DIFFICILE INFECTION#929229
- Microbiome-based therapeutics for Clostridioides difficile infection: additive, subtractive, and modulatory strategies in modern clinical practice.#610276
- Bacterial Membrane Vesicles as Versatile Platforms for Systemic and Mucosal Vaccines.#232438
- Detection of Diagnostic Antibodies in Immune-Mediated Diseases: A Focus on Antigens and Technologies.#148197
Record · ID 1475940
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive